We are live on
!
Find out more
AB
Amalgamated Bank Portfolio holdings
AUM
$14.5B
1-Year Est. Return
44.3%
This Fund
S&P 500
This Quarter
Est. Return
-3%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$12.9B
AUM Growth
-$678M
(-5%)
Cap. Flow
+$6.37M
Cap. Flow
% of AUM
0.05%
Top 10 Holdings %
Top 10 Hldgs %
23.8%
Holding
3,083
New
921
Increased
335
Reduced
1,799
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$60.7M |
| 2 |
Medtronic
MDT
|
+$35.8M |
| 3 |
Apple
AAPL
|
+$30.8M |
| 4 |
Microsoft
MSFT
|
+$28.5M |
| 5 |
Linde
LIN
|
+$24.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$21M |
| 2 |
iShares Russell 3000 ETF
IWV
|
+$15.3M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$13.9M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$13.2M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$10M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.64% |
| 2 | Financials | 13.28% |
| 3 | Healthcare | 13.15% |
| 4 | Consumer Discretionary | 12.03% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
John B. Sanfilippo & Son
JBSS
$967M
| $351K | ﹤0.01% |
4,201
-263
| -6% | -$21.8K |
|
1702
Cohen & Steers
CNS
$4.23B
| $350K | ﹤0.01% |
4,071
-307
| -7% | -$25.4K |
|
|
GBT
1703
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $350K | ﹤0.01% |
10,100
-688
| -6% | -$20.6K |
|
1704
Outset Medical
OM
$84.7M
| $348K | ﹤0.01% |
511
-35
| -6% | -$21.1K |
|
|
CCRN
1705
DELISTED
Cross Country Healthcare
CCRN
| $347K | ﹤0.01% |
16,001
-990
| -6% | -$21.5K |
|
|
DOOR
1706
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $347K | ﹤0.01% |
3,900
-310
| -7% | -$30.6K |
|
1707
Adaptive Biotechnologies
ADPT
$3.59B
| $346K | ﹤0.01% |
24,913
+2,285
| +10% | +$35.9K |
|
1708
Kelly Services Class A
KELYA
$514M
| $346K | ﹤0.01% |
15,944
-939
| -6% | -$18.3K |
|
1709
Central Pacific Financial
CPF
$1.02B
| $345K | ﹤0.01% |
12,376
-763
| -6% | -$22.1K |
|
|
MNTV
1710
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $345K | ﹤0.01% |
21,246
-1,596
| -7% | -$26.7K |
|
|
MAXR
1711
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $345K | ﹤0.01% |
8,751
-608
| -6% | -$18.6K |
|
|
CIM
1712
Chimera Investment
CIM
$1.04B
| $344K | ﹤0.01% |
9,532
-651
| -6% | -$25.9K |
|
1713
Collegium Pharmaceutical
COLL
$1.15B
| $343K | ﹤0.01% |
16,849
-1,098
| -6% | -$20.7K |
|
|
DHC
1714
Diversified Healthcare Trust
DHC
$2.15B
| $340K | ﹤0.01% |
106,214
-6,388
| -6% | -$19.5K |
|
1715
Titan International
TWI
$466M
| $340K | ﹤0.01% |
23,111
-1,385
| -6% | -$16.2K |
|
1716
Atlantic Union Bankshares
AUB
$6.02B
| $337K | ﹤0.01% |
9,177
-674
| -7% | -$26.9K |
|
1717
Children's Place
PLCE
$54.3M
| $337K | ﹤0.01% |
6,834
-437
| -6% | -$27.8K |
|
|
FSR
1718
DELISTED
Fisker Inc.
FSR
| $336K | ﹤0.01% |
26,065
-2,057
| -7% | -$25.8K |
|
|
ARR
1719
Armour Residential REIT
ARR
$2.33B
| $335K | ﹤0.01% |
7,971
-353
| -4% | -$15.7K |
|
1720
Hanmi Financial
HAFC
$945M
| $334K | ﹤0.01% |
13,553
-818
| -6% | -$21.1K |
|
1721
RPC Inc
RES
$1.24B
| $334K | ﹤0.01% |
31,260
-1,710
| -5% | -$13.6K |
|
1722
Evolent Health
EVH
$348M
| $333K | ﹤0.01% |
10,298
-660
| -6% | -$17.3K |
|
1723
Zumiez
ZUMZ
$332M
| $333K | ﹤0.01% |
8,718
-1,396
| -14% | -$60.7K |
|
1724
Relay Therapeutics
RLAY
$4.1B
| $332K | ﹤0.01% |
11,087
-828
| -7% | -$20.1K |
|
|
HNGR
1725
DELISTED
Hanger Inc.
HNGR
| $331K | ﹤0.01% |
18,053
-1,153
| -6% | -$21.1K |
|
Similar funds
JFG
IFP
BBVA
SSA
BGC
FGP
Amalgamated Bank's Q1 2022 Portfolio in Review
As of Q1 2022, Amalgamated Bank held 3,083 positions worth $12.9B, down 5% from $13.5B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Amalgamated Bank's Q1 2022 filing shows 921 new, 335 increased, 1,799 reduced and 24 closed positions. Its largest new stake was Accenture: 180,111 shares worth $60.7M. The largest sale was iShares Core S&P 500 ETF, an estimated $21M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Amalgamated Bank's largest Q1 2022 buy was Accenture: 180,111 shares worth $60.7M.
- Amalgamated Bank added most to Apple in Q1 2022, an estimated $30.8M increase.
- Amalgamated Bank's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $21M.
- Amalgamated Bank fully exited iShares Russell 3000 ETF in Q1 2022, selling an estimated $15.3M.
- Amalgamated Bank's ten largest holdings make up 24% of its $12.9B portfolio in Q1 2022.
- Amalgamated Bank opened 921 new positions and closed 24 in Q1 2022.
- Amalgamated Bank's portfolio value fell 5% quarter-over-quarter to $12.9B.
Based on Amalgamated Bank's 13F filing for Q1 2022, filed 30 Jun 2022.